series-c-plus
Stage
1
Investors
About
Kelso Pharma is a European specialty pharmaceutical company that acquires, develops and commercialises niche, branded and complex medicines for patients and healthcare systems across the UK and Europe. The company emphasises improving patient compliance and securing supply of its medicines and is backed by private equity firm Apposite Capital LLP.
Explore Kelso Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.